Cover Image
市場調查報告書

胰島素幫浦 (體外)的全球市場

Insulin Pumps (External)

出版商 Global Industry Analysts, Inc. 商品編碼 138674
出版日期 內容資訊 英文 205 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
胰島素幫浦 (體外)的全球市場 Insulin Pumps (External)
出版日期: 2017年10月01日 內容資訊: 英文 205 Pages
簡介

本報告提供全球胰島素幫浦 (體外) 市場相關調查,彙整市場趨勢與產品概要,各地區趨勢,及打入市場的主要企業的簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 胰島素幫浦:序論
    • 主要的優點提供成長的機會
    • 已開發國家有助於銷售額擴大
    • 美國:最大市場
    • 歐洲:潛力巨大的市場
    • 目前普及率低是巨大成長潛力
    • 糖尿病發病率上升:主要的推動市場要素
    • 糖尿病:經濟負擔評估
  • 競爭分析
    • 胰島素幫浦市場
    • 各製造廠商胰島素幫浦比較
    • 競爭環境
    • 對新加入企業而言高門檻
  • 值得一提的市場趨勢
    • 第二型糖尿病:貼片幫浦獲得製造商的關注
    • 預填胰島素濾芯受到歡迎
    • 智慧型幫浦的崛起 其他
  • 主要的推動市場要素與課題
  • 糖尿病和胰島素
    • 糖尿病
    • 風險因素
    • 類型
    • 長期性併發症
    • 血糖值檢驗
    • 胰島素
    • 胰臟
    • 胰島素的種類
    • 胰島素治療的目標
    • 胰島素遞送(給藥)系統 其他
  • 產品概要
  • 產品創新/引進
  • 近幾年的產業活動
  • 全球市場參與企業
    • Debiotech S.A.
    • F. Hoffmann-La Roche, Ltd.
    • Insulet Corp.
    • Medtronic Plc.
    • Sooil Development Co. Ltd.
    • Tandem Diabetes Care Inc.
    • Valeritas Inc.
    • Ypsomed Holding AG
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1511

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 15 companies including many key and niche players such as -

Debiotech S.A.
F. Hoffmann-La Roche, Ltd.
Insulet Corp.
Medtronic Plc.
Sooil Development Co. Ltd.
Tandem Diabetes Care Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Insulin Pumps: A Prelude
  • Key Benefits Offered Infuse Sustained Growth Opportunities
  • Developed Regions Underpin Sales Growth
  • The United States - The Largest Market
  • Europe - A Market with Vast Potential
  • Lower Current Penetration Leaves Significant Room for Growth
    • Table 1: Insulin Pumps Market by Region (2016): Percentage Breakdown of Number of Users for Established Markets and Rest of World (includes corresponding Graph/Chart)
    • Table 2: Insulin Pump Penetration Rate (as a % of Total Diabetics) in Type 1 Diabetic Patients by Country (2016) (includes corresponding Graph/Chart)
  • Rising Incidence of Diabetes - A Major Market Driving Factor
    • Table 3: Global Diabetic Population by Region (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 4: Top Ten Diabetic Countries by Number of Individuals with Diabetes for 2015 (includes corresponding Graph/Chart)
    • Table 5: Top Ten Diabetic Countries by Number of Individuals with Diabetes for 2040 (includes corresponding Graph/Chart)
  • Diabetes - Assessing the Economic Burden
    • Table 6: Diabetes Related Healthcare Expenditure by Region: 2015 & 2040 (in US$ Billion) (includes corresponding Graph/Chart)
    • Table 7: Major Spenders on Diabetes (2015): Annual Expenditure on Diabetes Treatment and Management in US$ Billion for Ten Leading Countries (includes corresponding Graph/Chart)

2. COMPETITIVE ANALYSIS

  • Insulin Pumps Market - Set for Interesting Road Ahead
    • Table 8: Leading Players in the Global External Insulin Pumps Market (2016): Percentage Breakdown of Value Sales for Insulet, J&J (Animas), Medtronic, Roche, Tandem and Others (includes corresponding Graph/Chart)
  • Comparison of Select Durable Insulin Pumps by Manufacturer
  • Medtronic Banks on New Solutions and Distribution Expansion to Retain Dominance
  • Tandem Sees Gradual Rise in Market Share
  • Ypsomed Eyes Brighter Prospects with YpsoPump
  • Medtrum - A New Entrant with a Strong Product
  • Competitive Landscape in the Insulin Patch Pump Market
  • Insulet's OmniPod Benefits from Lack of Close Competition in its League
    • Insulet Focuses on Advances in Technology and Services to Gain Market Share
  • Cellnovo's Patch Pump Combines Functionality and Cost-Effectiveness
  • Valeritas' V-Go - An Affordable Patch Pump for Type II Diabetics
    • Valeritas Struggles to Push Sales of V-Go
  • Tough Ground for New Entrants

3. NOTEWORTHY MARKET TRENDS

  • Type II Diabetes - A Market with Significant Potential
  • Patch Pumps Gain Manufacturer Attention
  • Prefilled Insulin Cartridges Gain Popularity over Manual Filling
  • The Rise of Smart Pumps - A Major Game Changer
  • Innovative Features Spruce Up the Market for Insulin Pumps
  • Artificial Pancreas System (APS) - The Future of Diabetes Care
  • Artificial Pancreas - Are We There Yet?
  • The Risk of Diabetes in Aging Populace Presents Opportunities for Insulin Pumps
    • Table 9: Percentage Growth of 65+ Population in North America, Europe, Asia, and Latin America (includes corresponding Graph/Chart)
    • Table 10: Global Population Statistics for the 65+ Age Group (2015) (includes corresponding Graph/Chart)
    • Table 11: Comparison of Aging Population by Country (1980, 2015 & 2050): Percentage Share of Population Aged Above-65 Years of the Overall Population for Select Countries (includes corresponding Graph/Chart)
    • Table 12: Life Expectancy for Select Countries in Number of Years: 2015 (includes corresponding Graph/Chart)
  • Alarming Rise in Obesity - A Business Case for Diabetes Care
  • Global Obesity Facts in a Nutshell
    • Table 13: Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 (includes corresponding Graph/Chart)
    • Table 14: Severely Obese Population (in Thousands) Worldwide by Country: 2014 & 2025 (includes corresponding Graph/Chart)
  • Diabetes in Developing Countries to Expand Opportunities
    • Table 15: Global External Insulin Pumps Market - Geographic Regions Ranked by % CAGR (Value Sales) for 2015-2022: Asia-Pacific, Latin America, US, Europe and Canada (includes corresponding Graph/Chart)

4. KEY MARKET DRIVERS AND CHALLENGES

  • ICR: A Key Factor to Success
  • Customer Satisfaction: Crucial to Stay Competitive
  • Expiry of Warranty Provides New Opportunities to Insulin Pump Makers
  • Undiagnosed Diabetes - A Key Challenge
  • Better Safety Review - A Growing Need for Insulin Pumps
  • Insulin Pump Training - Not Receiving Adequate Attention
  • Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged
  • Competition from Other Insulin Delivery Technologies Continues
  • Implantable Insulin Pumps - A Potential Threat to External Insulin Pumps
  • Lantus: A Threat to Insulin Pump Manufacturers

5. DIABETES & INSULIN - AN ABSTRACT

  • Diabetes - A Fatal Disease
  • Risk Factors for Diabetes
  • Types of Diabetes
  • Long Term Complications of Diabetes
  • Testing Sugar Levels: Easy and Accurate
  • Insulin
  • Pancreas: The Main Source of Insulin in Human Body
  • Types of Insulin
    • Types of Insulin & Onset of Action
  • Goal of Insulin Therapy
  • Insulin Delivery Systems
  • a. Syringes
  • b. Insulin Pens
  • c. Jet Injectors
  • d. Tablets
  • e. External Insulin Pumps
  • f. Artificial Pancreas
  • Insulin Delivery Technologies

6. PRODUCT OVERVIEW

  • Evolution of Insulin Pumps
  • Components of Insulin Pump
  • How Does an Insulin Pump Work?
  • Value-added Features of Modern Insulin Pumps
    • Bolus Calculators
    • Insulin on Board
    • Customized Alarms
    • Touch Bolus
    • Interface to PCs
    • Others
  • Insulin Pump Delivery Rates
  • Guidelines for Insulin Pump Usage
  • Advantages
  • More Accurate and Consistent
  • Enhances Blood Sugar Control in Pediatric Patients
  • Adjusting Time Zones While Traveling
  • Improves Quality of Life
  • Patient Convenience
  • Other Advantages
  • Disadvantages/Risks Involved in the Usage of Insulin Pumps
  • High Cost
  • High Involvement
  • Diabetic Ketoacidosis Risk
  • Glucose Testing at Regular Intervals
  • Regular Rotation of Infusion Set
  • Carrying Back-up Kit
  • Regular Refilling of Pump
  • Other Disadvantages

7. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Medtronic Rolls Out MiniMed(tm) 670G System
  • Tandem Unveils New Software Update for t:slim(r) Insulin Pumps
  • Tandem Introduces t:slim X2(tm) Insulin Pump with Dexcom G5(r) Mobile CGM Integration
  • Tandem Launches t:lock(tm) Connector
  • Tandem Receives US Patent for Infusion Pump and Electronic Device Integration
  • SOOIL Development Unveils DANA Diabecare RS Insulin Pump
  • Cellnovo Files FDA 510(k) Clearance for Diabetes Management System
  • Medtronic Obtains FDA Nod for its New MiniMed(r) 670G System
  • Medtrum Launches Medtrum P6 Tubeless Insulin Pump
  • Medtronic Launches MiniMed(r) 630G System
  • Tandem Secures FDA Expanded Indication for t:slim(r) Insulin Pump
  • EMA Clears Use of mylife(tm) YpsoPump(r) with NovoRapid(r) PumpCart(r)
  • Animas Receives FDA Expanded Indication for Animas(r) Vibe(r) Insulin Pump in Children
  • Medtronic Introduces MiniMed Connect System for Insulin Pumps and CGMs
  • Tandem Gets FDA Nod for t:slim G4 Insulin Pump
  • Unilife Rolls Out Instant Patch Pumps Platform - Imperium(tm)
  • Medtronic Rolls Out MiniMed(tm) 640G System
  • Tandem Bags FDA Clearance for t:flex Insulin Pump

8. RECENT INDUSTRY ACTIVITY

  • Animas Decides to Exit Insulin Pump Business
  • Tandem to Commence At-Home Pivotal Trial for t:slim X2(tm) Insulin Pump
  • Aspire Capital Fund to Invest in Valeritas Holdings
  • Roche Diabetes Care Discontinues Accu-Chek Brand in the US
  • Insulet to Distribute its Omnipod System in Europe
  • Valeritas Achieves Better Results with V-Go(r) Device
  • Valeritas Shows Quality Results with V-Go(r) Wearable Device
  • Medtronic Collaborates with Aetna
  • Roche to Acquire mySugr
  • Tandem Announces Order Intake for t:slim X2(tm) Insulin Pump
  • Bigfoot Secure FDA's Clearance for Artificial Pancreas Trial
  • Tandem Inks Technology Licensing Deal with TypeZero
  • Ypsomed and Novo Nordisk Sign Pact for mylife(tm) YpsoPump(r)
  • UnitedHealth Group Selects Medtronic As Exclusive Supplier of Insulin Pumps
  • Cellnovo and Roche Enter into Commercial Agreement for BGM
  • Insulet Inks Deal with Mode for Licensing Artificial Pancreas Algorithm
  • Ypsomed Expands Availability of mylife(tm) OmniPod(r) in Europe
  • Medtronic Enters into Agreement with Chengdu Government to Produce Insulin Pumps
  • Insulet and Eli Lilly Team Up to Develop New Version of OmniPod for Delivering Lilly's Humalog
  • Tandem and Dexcom Ink Deal to Pair their Devices
  • BD Medical and Medtronic Collaborate to Launch New Infusion Set
  • Bigfoot Biomedical Takes Over Asante Solutions
  • Debiotech to Take Over Rights to iSense CGM
  • Medtronic Acquires Covidien

9. FOCUS ON SELECT PLAYERS

  • Debiotech S.A. (Switzerland)
  • F. Hoffmann-La Roche, Ltd. (Switzerland)
  • Insulet Corp. (USA)
  • Medtronic Plc. (Ireland)
  • Sooil Development Co. Ltd. (Korea)
  • Tandem Diabetes Care Inc. (USA)
  • Valeritas Inc. (USA)
  • Ypsomed Holding AG (Switzerland)

10. GLOBAL MARKET PERSPECTIVE

    • Table 16: World Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 17: World Historic Review for Insulin Pumps (External) by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 18: World 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • The Prime Market for Insulin Pumps
    • Table 19: Diabetes Statistics in the US (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s)
    • Table 20: Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart)
    • Table 21: Diabetes Prevalence in the US (2015): Percentage Share of Number of Diabetics by Gender (includes corresponding Graph/Chart)
    • Table 22: Diabetes Prevalence in the US (2015): Percentage Share of Number of Diabetics by Age Group (includes corresponding Graph/Chart)
    • Table 23: US Market for Diabetes Management (2015 & 2018P): Percentage Share Breakdown by Treatment Type (includes corresponding Graph/Chart)
    • Increasing Inclination towards Patch Pumps
    • Artificial Pancreas System (APS): The Future of Diabetes Management
      • Select Clinical Studies on Artificial Pancreas Technology
    • Competitive Scenario
      • Comparison of Select Insulin Pump Systems Available in the US
    • Reimbursements
    • Regulatory Scenario
      • FDA Announces a New Mandate for Manufacturing Companies
    • Product Approvals/Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 24: The US Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 25: The US Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Diabetes Statistics
    • Table 26: Prevalence of Adult Diabetes in Canada by Gender (2010-2014): Number of Adult Males and Females Aged 12 Years and Over Diagnosed with Diabetes (In Thousands) (includes corresponding Graph/Chart)
    • Table 27: Prevalence of Adult Diabetes in Canada by Age Group (2010-2014): Number of Adult Males and Females with Diabetes by Age Group (In Thousands) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 28: Canadian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 29: Canadian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Market Overview
      • Regional Scenario
    • Diabetes Prevalence in Europe
    • Table 30: Diabetes Prevalence in Europe (2015): Prevalence of Type I & Type II Diabetes As Percentage of Adult Population (Aged 20 to 79 Years) by Country (includes corresponding Graph/Chart)
    • Product Approval
  • B. Market Analytics
    • Table 31: European Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 32: European Historic Review for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 33: European 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

3a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 34: French Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 35: French Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3b. GERMANY

  • Market Analysis
    • Table 36: German Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 37: German Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3c. ITALY

  • Market Analysis
    • Table 38: Italian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 39: Italian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Enhanced Focus on Diabetes Management Drives Demand
    • INPUT (The Insulin Pump Therapy Group)
    • NICE (National Institute of Clinical Excellence)
    • Product Launch
  • B. Market Analytics
    • Table 40: The UK Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 41: The UK Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3e. SPAIN

  • Market Analysis
    • Table 42: Spanish Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 43: Spanish Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3f. RUSSIA

  • Market Analysis
    • Table 44: Russian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 45: Russian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3g. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 46: Rest of Europe Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 47: Rest of Europe Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. ASIA-PACIFIC

  • A. Market Analysis
    • Asia-Pacific: A Rapidly Growing Market
    • Table 48: Diabetes and Population Statistics in South East Asia (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 49: Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Table 50: Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 51: Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Review of Select Markets
      • China
      • Overview
      • China: An Untapped Goldmine
      • India
      • Diabetes Scenario
      • Insulin Pumps Market in India - An Overview
      • New Indigenously Developed Product Could be the Answer
      • Medtronic: The Current Market Leader
      • Diabetic Epidemic Spurs Indian Market
    • Strategic Corporate Development
    • Key Player
  • B. Market Analytics
    • Table 52: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 53: Asia-Pacific Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

5. LATIN AMERICA

  • A. Market Analysis
    • Current & Future Analysis
    • Growing Population of Diabetics Spurs Demand
    • Table 54: Diabetes and Population Statistics in Central and South America (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 55: Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • A Peek in to the Brazilian Insulin Pumps Market
  • B. Market Analytics
    • Table 56: Latin American Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 57: Latin American Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Growing Prevalence of Diabetes: Key Market Driver
    • Table 58: African Diabetes and Population Statistics (2015 & 2040P) (includes corresponding Graph/Chart)
    • Table 59: Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Table 60: Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 61: Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 62: Rest of World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 63: Rest of World Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top